Funding Briefs

Man Versus Man William Wordsworth waxed poetic about “man’s inhumanity to man,” but the more broadminded Harry Frank Guggenheim was interested in studying, as he put it, “man’s relation to man.” In keeping with that idea, the New York foundation that Guggenheim endowed in 1929 has traditionally sponsored a seven-part international program of scientific research aimed at better understanding the causes of dominance, violence, and aggression. Now an eighth a

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

William Wordsworth waxed poetic about “man’s inhumanity to man,” but the more broadminded Harry Frank Guggenheim was interested in studying, as he put it, “man’s relation to man.” In keeping with that idea, the New York foundation that Guggenheim endowed in 1929 has traditionally sponsored a seven-part international program of scientific research aimed at better understanding the causes of dominance, violence, and aggression.

Now an eighth area is being considered: the foundation might make small contributions to charities actively addressing social problems in these areas. Since the program is in its formative stage, unsolicited grant proposals will not be considered; the charity organizations must be nominated in a letter from a current Guggenheim grantee or from a scientist currently involved in related research.

The reason for this procedure, explains program assistant Ellen Agoratus, is twofold: the scientist/nominators act as an unofficial pre-screening mechanism by recommending - nonprof its they know ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies